BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32708333)

  • 1. Compound Prunetin Induces Cell Death in Gastric Cancer Cell with Potent Anti-Proliferative Properties: In Vitro Assay, Molecular Docking, Dynamics, and ADMET Studies.
    Vetrivel P; Kim SM; Ha SE; Kim HH; Bhosale PB; Senthil K; Kim GS
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32708333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-Bound Polysaccharides from
    Pawlikowska M; Jędrzejewski T; Brożyna AA; Wrotek S
    Cell Physiol Biochem; 2020 Jun; 54(4):591-604. PubMed ID: 32531147
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Zhang H; Xu L; Qin X; Chen X; Cong H; Hu L; Chen L; Miao Z; Zhang W; Cai Z; Zhuang C
    J Med Chem; 2019 Jul; 62(14):6665-6681. PubMed ID: 31095385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RIPK1 inhibitor Cpd-71 attenuates renal dysfunction in cisplatin-treated mice via attenuating necroptosis, inflammation and oxidative stress.
    Wang JN; Liu MM; Wang F; Wei B; Yang Q; Cai YT; Chen X; Liu XQ; Jiang L; Li C; Hu XW; Yu JT; Ma TT; Jin J; Wu YG; Li J; Meng XM
    Clin Sci (Lond); 2019 Jul; 133(14):1609-1627. PubMed ID: 31315969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation on the cellular mechanism of Prunetin evidenced through next generation sequencing and bioinformatic approaches against gastric cancer.
    Vetrivel P; Nachimuthu S; Abuyaseer A; Bhosale PB; Ha SE; Kim HH; Park MY; Kim GS
    Sci Rep; 2022 Jul; 12(1):11852. PubMed ID: 35831348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumol induces RIPK1/RIPK3 complex-dependent necroptosis via JNK1/2-ROS signaling in hepatic stellate cells.
    Jia Y; Wang F; Guo Q; Li M; Wang L; Zhang Z; Jiang S; Jin H; Chen A; Tan S; Zhang F; Shao J; Zheng S
    Redox Biol; 2018 Oct; 19():375-387. PubMed ID: 30237126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the Raf kinase inhibitor TAK-632 and its analogues as potent inhibitors of necroptosis by targeting RIPK1 and RIPK3.
    Chen X; Zhuang C; Ren Y; Zhang H; Qin X; Hu L; Fu J; Miao Z; Chai Y; Liu ZG; Zhang H; Cai Z; Wang HY
    Br J Pharmacol; 2019 Jun; 176(12):2095-2108. PubMed ID: 30825190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Bcr-Abl inhibitor GNF-7 inhibits necroptosis and ameliorates acute kidney injury by targeting RIPK1 and RIPK3 kinases.
    Qin X; Hu L; Shi SN; Chen X; Zhuang C; Zhang W; Jitkaew S; Pang X; Yu J; Tan YX; Wang HY; Cai Z
    Biochem Pharmacol; 2020 Jul; 177():113947. PubMed ID: 32247850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis.
    Hou J; Ju J; Zhang Z; Zhao C; Li Z; Zheng J; Sheng T; Zhang H; Hu L; Yu X; Zhang W; Li Y; Wu M; Ma H; Zhang X; He S
    Cell Death Dis; 2019 Jun; 10(7):493. PubMed ID: 31235688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neurotoxicant PCB-95 by increasing the neuronal transcriptional repressor REST down-regulates caspase-8 and increases Ripk1, Ripk3 and MLKL expression determining necroptotic neuronal death.
    Guida N; Laudati G; Serani A; Mascolo L; Molinaro P; Montuori P; Di Renzo G; Canzoniero LMT; Formisano L
    Biochem Pharmacol; 2017 Oct; 142():229-241. PubMed ID: 28676433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celastrol Induces Necroptosis and Ameliorates Inflammation via Targeting Biglycan in Human Gastric Carcinoma.
    Guo D; Zhang W; Yang H; Bi J; Xie Y; Cheng B; Wang Y; Chen S
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ophiopogonin D' induces RIPK1‑dependent necroptosis in androgen‑dependent LNCaP prostate cancer cells.
    Lu Z; Wu C; Zhu M; Song W; Wang H; Wang J; Guo J; Li N; Liu J; Li Y; Xu H
    Int J Oncol; 2020 Feb; 56(2):439-447. PubMed ID: 31894265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prunetin inhibits nitric oxide activity and induces apoptosis in urinary bladder cancer cells via CASP3 and TNF-α genes.
    Köksal Karayildirim Ç; Nalbantsoy A; Karabay Yavaşoğlu NÜ
    Mol Biol Rep; 2021 Nov; 48(11):7251-7259. PubMed ID: 34599704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytosolic calcium mediates RIP1/RIP3 complex-dependent necroptosis through JNK activation and mitochondrial ROS production in human colon cancer cells.
    Sun W; Wu X; Gao H; Yu J; Zhao W; Lu JJ; Wang J; Du G; Chen X
    Free Radic Biol Med; 2017 Jul; 108():433-444. PubMed ID: 28414098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-benzoquinone geldanamycin analogs trigger various forms of death in human breast cancer cells.
    Zhang Z; Li HM; Zhou C; Li Q; Ma L; Zhang Z; Sun Y; Wang L; Zhang X; Zhu B; Hong YS; Wu CZ; Liu H
    J Exp Clin Cancer Res; 2016 Sep; 35(1):149. PubMed ID: 27658586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Necrostatin-1 accelerates time to death in a rat model of cecal ligation and puncture and massively increases hepatocyte caspase-3 cleavage.
    Zhang Q; Wei S; Lu J; Fu W; Chen H; Huang Q; Chen Z; Zeng Z
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G551-G561. PubMed ID: 30735454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RIPK1/RIPK3/MLKL-mediated necroptosis contributes to compression-induced rat nucleus pulposus cells death.
    Chen S; Lv X; Hu B; Shao Z; Wang B; Ma K; Lin H; Cui M
    Apoptosis; 2017 May; 22(5):626-638. PubMed ID: 28289909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II triggers RIPK3-MLKL-mediated necroptosis by activating the Fas/FasL signaling pathway in renal tubular cells.
    Zhu Y; Cui H; Lv J; Li G; Li X; Ye F; Zhong L
    PLoS One; 2020; 15(3):e0228385. PubMed ID: 32134954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligustroflavone reduces necroptosis in rat brain after ischemic stroke through targeting RIPK1/RIPK3/MLKL pathway.
    Zhang YY; Liu WN; Li YQ; Zhang XJ; Yang J; Luo XJ; Peng J
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Sep; 392(9):1085-1095. PubMed ID: 31055628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of novel HER2 inhibitors against gastric cancer derived from flavonoid source of
    Babu TM; Rammohan A; Baki VB; Devi S; Gunasekar D; Rajendra W
    Drug Des Devel Ther; 2016; 10():3611-3632. PubMed ID: 27853354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.